📊 PMHS Key Takeaways
Is Polomar Health Services, Inc. (PMHS) a Good Investment?
Polomar Health Services is in severe financial distress with a liquidity crisis that threatens near-term viability. The company operates with a dangerously thin cash position of $38.9K while burning $586K annually in operating cash flow, leaving minimal runway. Massive operating losses of $1.6M dwarf minimal revenue of $16.2K, indicating fundamental operational challenges despite a healthy gross margin.
Why Buy Polomar Health Services, Inc. Stock? PMHS Key Strengths
- 70.1% gross margin indicates viable product economics if revenue scaled
- Positive stockholders equity of $7.8M provides some balance sheet cushion
- Revenue grew 40.6% YoY from an admittedly small base
PMHS Stock Risks: Polomar Health Services, Inc. Investment Risks
- Critical liquidity crisis: current ratio of 0.13x and quick ratio of 0.03x indicate inability to cover short-term obligations
- Cash reserves of only $38.9K with annual operating cash burn of $586K suggests imminent insolvency without capital injection
- Operating losses of $1.6M vastly exceed $16.2K revenue, signaling fundamental business model failure at current scale
- Negative operating and free cash flow with ongoing capital expenditures suggests unsustainable cash depletion trajectory
- No insider trading activity suggests lack of management confidence in company trajectory
Key Metrics to Watch
- Cash balance and monthly burn rate - company faces acute solvency risk within months
- Revenue trajectory and path to profitability - current $16.2K quarterly run-rate is untenable
- Operating cash flow trend - must turn positive or company will deplete remaining cash reserves
Polomar Health Services, Inc. (PMHS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
PMHS Profit Margin, ROE & Profitability Analysis
PMHS vs Healthcare Sector: How Polomar Health Services, Inc. Compares
How Polomar Health Services, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Polomar Health Services, Inc. Stock Overvalued? PMHS Valuation Analysis 2026
Based on fundamental analysis, Polomar Health Services, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Polomar Health Services, Inc. Balance Sheet: PMHS Debt, Cash & Liquidity
PMHS Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Polomar Health Services, Inc.'s revenue has grown significantly by 70% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.02 indicates the company is currently unprofitable.
PMHS Revenue Growth, EPS Growth & YoY Performance
PMHS Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $6.2K | -$271.3K | $-0.01 |
| Q2 2025 | $5.5K | -$160.5K | $-0.01 |
| Q1 2025 | $4.5K | -$160.5K | $-0.01 |
| Q3 2024 | $9.8K | -$160.5K | $0.00 |
| Q3 2023 | $4.5K | -$2.3K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Polomar Health Services, Inc. Dividends, Buybacks & Capital Allocation
PMHS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Polomar Health Services, Inc. (CIK: 0001265521)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PMHS
What is the AI rating for PMHS?
Polomar Health Services, Inc. (PMHS) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PMHS's key strengths?
Claude: 70.1% gross margin indicates viable product economics if revenue scaled. Positive stockholders equity of $7.8M provides some balance sheet cushion.
What are the risks of investing in PMHS?
Claude: Critical liquidity crisis: current ratio of 0.13x and quick ratio of 0.03x indicate inability to cover short-term obligations. Cash reserves of only $38.9K with annual operating cash burn of $586K suggests imminent insolvency without capital injection.
What is PMHS's revenue and growth?
Polomar Health Services, Inc. reported revenue of $16.2K.
Does PMHS pay dividends?
Polomar Health Services, Inc. does not currently pay dividends.
Where can I find PMHS SEC filings?
Official SEC filings for Polomar Health Services, Inc. (CIK: 0001265521) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PMHS's EPS?
Polomar Health Services, Inc. has a diluted EPS of $-0.06.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is PMHS a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Polomar Health Services, Inc. has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is PMHS stock overvalued or undervalued?
Valuation metrics for PMHS: ROE of -22.0% (sector avg: 15%), net margin of -10,586.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy PMHS stock in 2026?
Our dual AI analysis gives Polomar Health Services, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PMHS's free cash flow?
Polomar Health Services, Inc.'s operating cash flow is $-586.0K, with capital expenditures of $90.9K. FCF margin is -4,185.2%.
How does PMHS compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -10,586.1% (avg: 12%), ROE -22.0% (avg: 15%), current ratio 0.13 (avg: 2).